| Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2016: ¥520,000 (Direct Cost: ¥400,000、Indirect Cost: ¥120,000)
Fiscal Year 2015: ¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
|
|---|
| Outline of Final Research Achievements |
This study examined the quality of life (QOL) of patients with chronic obstructive pulmonary disease (COPD) prior to the start of chemotherapy for non-small-cell lung cancer and for up to 6 months afterwards. The results indicated that these patients tended to have a lower QOL than patients with non-small-cell lung cancer in previous studies. Lessening of the degree of shortness of breath and the response to treatment are linked to a shorter period of inactivity and presumably contribute to increased muscle mass in the extremities. However, patients tended to have fewer individuals providing support 3 and 6 months after the start of treatment than they had prior to the start of treatment. Continuing treatment presumably affects a patient’s social life and family. Patients with COPD and non-small-cell lung cancer need relief of such symptoms as shortness of breath, but interventions for improving their relationships with family members and maintaining weight are also crucial.
|
